KEY FEATURES
| Full Name | glial fibrillary acidic protein |
|---|---|
| Synonym | Intermediate Filament Protein |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 15.63-1000pg/mL |
| Sensitivity | 9.38pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse GFAP in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse GFAP. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse GFAP and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse GFAP, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse GFAP. You can calculate the concentration of Mouse GFAP in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse GFAP ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 47.5 | 109.2 | 437.59 | 43.46 | 105.02 | 460 |
| Standard deviation | 2.6 | 6.29 | 14.27 | 2.26 | 5.14 | 15.5 |
| CV(%) | 5.47 | 5.76 | 3.26 | 5.2 | 4.89 | 3.37 |
RECOVERY
The recovery of Mouse GFAP spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-105 | 100 |
| EDTA plasma (n=8) | 90-100 | 95 |
| Cell culture media (n=8) | 89-102 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse GFAP in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Pathways associated with ELISA Kit
| Neural Crest Differentiation Pathway | Neural Crest Differentiation Pathway |
| Nuclear Signaling By ERBB4 Pathway | Nuclear Signaling By ERBB4 Pathway |
| Signal Transduction Pathway | Signal Transduction Pathway |
| Signaling By ERBB4 Pathway | Signaling By ERBB4 Pathway |
| Spinal Cord Injury Pathway | Spinal Cord Injury Pathway |
Diseases associated with GFAP ELISA Kit
| Nervous System Diseases | publications with GFAP and Nervous System Diseases |
| Brain Diseases | publications with GFAP and Brain Diseases |
| Disease Models, Animal | publications with GFAP and Disease Models, Animal |
| Gliosis | publications with GFAP and Gliosis |
| Cardiovascular Diseases | publications with GFAP and Cardiovascular Diseases |
| Brain Injuries | publications with GFAP and Brain Injuries |
| Inflammation | publications with GFAP and Inflammation |
| Necrosis | publications with GFAP and Necrosis |
| Nerve Degeneration | publications with GFAP and Nerve Degeneration |
| Epilepsy | publications with GFAP and Epilepsy |
Organs/Tissues associated with GFAP ELISA Kit
| Brain | publications with GFAP and Brain |
| Nerve | publications with GFAP and Nerve |
| Blood | publications with GFAP and Blood |
| Spinal Cord | publications with GFAP and Spinal Cord |
| Eye | publications with GFAP and Eye |
| Muscle | publications with GFAP and Muscle |
| Ganglia | publications with GFAP and Ganglia |
| Bone Marrow | publications with GFAP and Bone Marrow |
| Liver | publications with GFAP and Liver |
| Connective Tissue | publications with GFAP and Connective Tissue |